244 related articles for article (PubMed ID: 16497810)
1. Phosphatidylinositol 3-kinase and glycogen synthase kinase 3 regulate estrogen receptor-mediated transcription in neuronal cells.
Mendez P; Garcia-Segura LM
Endocrinology; 2006 Jun; 147(6):3027-39. PubMed ID: 16497810
[TBL] [Abstract][Full Text] [Related]
2. Resveratrol modulates the phosphoinositide 3-kinase pathway through an estrogen receptor alpha-dependent mechanism: relevance in cell proliferation.
Pozo-Guisado E; Lorenzo-Benayas MJ; Fernández-Salguero PM
Int J Cancer; 2004 Mar; 109(2):167-73. PubMed ID: 14750165
[TBL] [Abstract][Full Text] [Related]
3. Up-regulation of PI3K/Akt signaling by 17beta-estradiol through activation of estrogen receptor-alpha, but not estrogen receptor-beta, and stimulates cell growth in breast cancer cells.
Lee YR; Park J; Yu HN; Kim JS; Youn HJ; Jung SH
Biochem Biophys Res Commun; 2005 Nov; 336(4):1221-6. PubMed ID: 16169518
[TBL] [Abstract][Full Text] [Related]
4. Glycogen synthase kinase 3 has a limited role in cell cycle regulation of cyclin D1 levels.
Yang K; Guo Y; Stacey WC; Harwalkar J; Fretthold J; Hitomi M; Stacey DW
BMC Cell Biol; 2006 Aug; 7():33. PubMed ID: 16942622
[TBL] [Abstract][Full Text] [Related]
5. Phosphatidylinositol-3-OH Kinase (PI3K)/AKT2, activated in breast cancer, regulates and is induced by estrogen receptor alpha (ERalpha) via interaction between ERalpha and PI3K.
Sun M; Paciga JE; Feldman RI; Yuan Z; Coppola D; Lu YY; Shelley SA; Nicosia SV; Cheng JQ
Cancer Res; 2001 Aug; 61(16):5985-91. PubMed ID: 11507039
[TBL] [Abstract][Full Text] [Related]
6. Nectandrin B activates endothelial nitric-oxide synthase phosphorylation in endothelial cells: role of the AMP-activated protein kinase/estrogen receptor α/phosphatidylinositol 3-kinase/Akt pathway.
Hien TT; Oh WK; Nguyen PH; Oh SJ; Lee MY; Kang KW
Mol Pharmacol; 2011 Dec; 80(6):1166-78. PubMed ID: 21940786
[TBL] [Abstract][Full Text] [Related]
7. delta-Opioid receptor-stimulated Akt signaling in neuroblastoma x glioma (NG108-15) hybrid cells involves receptor tyrosine kinase-mediated PI3K activation.
Heiss A; Ammer H; Eisinger DA
Exp Cell Res; 2009 Jul; 315(12):2115-25. PubMed ID: 19362548
[TBL] [Abstract][Full Text] [Related]
8. An inherent role of integrin-linked kinase-estrogen receptor alpha interaction in cell migration.
Acconcia F; Manavathi B; Mascarenhas J; Talukder AH; Mills G; Kumar R
Cancer Res; 2006 Nov; 66(22):11030-8. PubMed ID: 17108142
[TBL] [Abstract][Full Text] [Related]
9. Estrogen receptor beta signaling through phosphatase and tensin homolog/phosphoinositide 3-kinase/Akt/glycogen synthase kinase 3 down-regulates blood-brain barrier breast cancer resistance protein.
Hartz AM; Madole EK; Miller DS; Bauer B
J Pharmacol Exp Ther; 2010 Aug; 334(2):467-76. PubMed ID: 20460386
[TBL] [Abstract][Full Text] [Related]
10. Insulin-like growth factor binding protein-4 and -5 modulate ligand-dependent estrogen receptor-α activation in breast cancer cells in an IGF-independent manner.
Hermani A; Shukla A; Medunjanin S; Werner H; Mayer D
Cell Signal; 2013 Jun; 25(6):1395-402. PubMed ID: 23499909
[TBL] [Abstract][Full Text] [Related]
11. WNT unrelated activities in commercially available preparations of recombinant WNT3a.
Cajanek L; Adlerz L; Bryja V; Arenas E
J Cell Biochem; 2010 Dec; 111(5):1077-9. PubMed ID: 20665540
[TBL] [Abstract][Full Text] [Related]
12. Forkhead box transcription factor FOXO3a regulates estrogen receptor alpha expression and is repressed by the Her-2/neu/phosphatidylinositol 3-kinase/Akt signaling pathway.
Guo S; Sonenshein GE
Mol Cell Biol; 2004 Oct; 24(19):8681-90. PubMed ID: 15367686
[TBL] [Abstract][Full Text] [Related]
13. Akt stabilizes estrogen receptor alpha with the concomitant reduction in its transcriptional activity.
Park S; Song J; Joe CO; Shin I
Cell Signal; 2008 Jul; 20(7):1368-74. PubMed ID: 18450422
[TBL] [Abstract][Full Text] [Related]
14. High glucose impaired estrogen receptor alpha signaling via β-catenin in osteoblastic MC3T3-E1.
Wang R; Gao D; Zhou Y; Chen L; Luo B; Yu Y; Li H; Hu J; Huang Q; He M; Peng W; Luo D
J Steroid Biochem Mol Biol; 2017 Nov; 174():276-283. PubMed ID: 29030155
[TBL] [Abstract][Full Text] [Related]
15. Insulin-like growth factor-I inhibits progesterone receptor expression in breast cancer cells via the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin pathway: progesterone receptor as a potential indicator of growth factor activity in breast cancer.
Cui X; Zhang P; Deng W; Oesterreich S; Lu Y; Mills GB; Lee AV
Mol Endocrinol; 2003 Apr; 17(4):575-88. PubMed ID: 12554765
[TBL] [Abstract][Full Text] [Related]
16. Cross-talk between IGF-I and estradiol in the brain: focus on neuroprotection.
Garcia-Segura LM; Sanz A; Mendez P
Neuroendocrinology; 2006; 84(4):275-9. PubMed ID: 17124377
[TBL] [Abstract][Full Text] [Related]
17. Glycogen synthase kinase 3 beta is a natural activator of mitogen-activated protein kinase/extracellular signal-regulated kinase kinase kinase 1 (MEKK1).
Kim JW; Lee JE; Kim MJ; Cho EG; Cho SG; Choi EJ
J Biol Chem; 2003 Apr; 278(16):13995-4001. PubMed ID: 12584189
[TBL] [Abstract][Full Text] [Related]
18. Various phosphorylation pathways, depending on agonist and antagonist binding to endogenous estrogen receptor alpha (ERalpha), differentially affect ERalpha extractability, proteasome-mediated stability, and transcriptional activity in human breast cancer cells.
Marsaud V; Gougelet A; Maillard S; Renoir JM
Mol Endocrinol; 2003 Oct; 17(10):2013-27. PubMed ID: 12855746
[TBL] [Abstract][Full Text] [Related]
19. Gonadotropin-induced apoptosis in human ovarian surface epithelial cells is associated with cyclooxygenase-2 up-regulation via the beta-catenin/T-cell factor signaling pathway.
Pon YL; Wong AS
Mol Endocrinol; 2006 Dec; 20(12):3336-50. PubMed ID: 16945989
[TBL] [Abstract][Full Text] [Related]
20. Regulation of the RAP1/RAF-1/extracellularly regulated kinase-1/2 cascade and prolactin release by the phosphoinositide 3-kinase/AKT pathway in pituitary cells.
Romano D; Pertuit M; Rasolonjanahary R; Barnier JV; Magalon K; Enjalbert A; Gerard C
Endocrinology; 2006 Dec; 147(12):6036-45. PubMed ID: 16935846
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
